{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:37:18Z","timestamp":1784954238184,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jvir.2026.108588","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:28:17Z","timestamp":1771288097000},"page":"108588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence of Bleomycin-Induced Hyperpigmentation in Patients Undergoing Sclerotherapy for Low-Flow Vascular Malformations"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7901-8179","authenticated-orcid":false,"given":"Noah","family":"Tregobov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8805-3670","authenticated-orcid":false,"given":"Rebecca","family":"Courtemanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-3369","authenticated-orcid":false,"given":"Joseph","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3720-9302","authenticated-orcid":false,"given":"Douglas J.","family":"Courtemanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0040-6054","authenticated-orcid":false,"given":"Manraj K.S.","family":"Heran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2026.108588_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0009-2797(90)90001-4","article-title":"The role of redox-active metals in the mechanism of action of bleomycin","volume":"73","author":"Petering","year":"1990","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jvir.2026.108588_bib2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.7326\/0003-4819-90-6-945","article-title":"Bleomycin","volume":"90","author":"Bennett","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jvir.2026.108588_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PRS.0000000000001924","article-title":"Intralesional bleomycin injections for vascular malformations: a systematic review and meta-analysis","volume":"137","author":"Horbach","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jvir.2026.108588_bib4","article-title":"The efficacy of bleomycin sclerotherapy in the treatment of lymphatic malformations: a review and meta-analysis","volume":"89","author":"Sun","year":"2023","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.jvir.2026.108588_bib5","article-title":"Intralesional injection of bleomycin in the management of low flow vascular malformations: results and factors affecting the outcome","volume":"12","author":"Abdelaty","year":"2024","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jvir.2026.108588_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cjprs.2022.08.007","article-title":"Efficacy and safety of sclerosants in the treatment of venous malformations: a network meta-analysis of randomized controlled trials","volume":"4","author":"L\u00fc","year":"2022","journal-title":"Chin J Plast Reconstr Surg"},{"key":"10.1016\/j.jvir.2026.108588_bib7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.2006.07474.x","article-title":"Bleomycin and the skin","volume":"155","author":"Yamamoto","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jvir.2026.108588_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2165\/11537080-000000000-00000","article-title":"Flagellate dermatitis as a bleomycin-specific adverse effect of cytostatic therapy: a clinical-histopathologic correlation","volume":"12","author":"Ziemer","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jvir.2026.108588_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5070\/D31KK948KN","article-title":"Palmar and flagellate hyperpigmentation following low dose intralesional injection of bleomycin for cystic hygroma","volume":"14","author":"Manoj","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jvir.2026.108588_bib10","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1111\/pde.13297","article-title":"Bleomycin-induced flagellate erythema after venous malformation sclerosis-case report and brief review","volume":"35","author":"Pinto","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jvir.2026.108588_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/derm.2024.0406","article-title":"Flagellate erythema induced by bleomycin as a sclerosant agent in the treatment of venous malformation","volume":"36","author":"Y\u00fcksek","year":"2025","journal-title":"Dermatitis"},{"key":"10.1016\/j.jvir.2026.108588_bib12","article-title":"A decade of bleomycin","volume":"6","author":"Miller","year":"2025","journal-title":"J Vasc Anom (Phila)"},{"key":"10.1016\/j.jvir.2026.108588_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/pde.14869","article-title":"Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations","volume":"39","author":"Davis","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jvir.2026.108588_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27008","article-title":"Short-term side effects and patient-reported outcomes of bleomycin sclerotherapy in vascular malformations","volume":"65","author":"Mack","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jvir.2026.108588_bib15","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jvir.2018.10.007","article-title":"Hyperpigmentation after foamed bleomycin sclerotherapy for vascular malformations","volume":"30","author":"Milbar","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.108588_bib16","unstructured":"BC Cancer Agency, Bleomycin monograph. BC Cancer Drug Database. Revised December 1, 2014. Available at: https:\/\/www.bccancer.bc.ca\/drug-database-site\/Drug%20Index\/Bleomycin_monograph_1Dec2014.pdf. Accessed April 27, 2025"},{"issue":"Suppl 5","key":"10.1016\/j.jvir.2026.108588_bib17","first-page":"3","article-title":"Bleomycin pharmacology: mechanism of action and resistance, and clinical pharmacokinetics","volume":"19","author":"Dorr","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jvir.2026.108588_bib18","article-title":"Utilizing cohesive bandage to prevent adverse effects of bleomycin sclerotherapy: a case report","volume":"17","author":"Paluska","year":"2023","journal-title":"A A Pract"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044326005993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044326005993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:23:47Z","timestamp":1778941427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044326005993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1051044326005993"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2026.108588","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Bleomycin-Induced Hyperpigmentation in Patients Undergoing Sclerotherapy for Low-Flow Vascular Malformations","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2026.108588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR 2026 .","name":"copyright","label":"Copyright"}],"article-number":"108588"}}